
After a median follow-up of 10 months, the overall response rate in patients with PD-L1-expressing metastatic breast cancer was 33.3 percent.
After a median follow-up of 10 months, the overall response rate in patients with PD-L1-expressing metastatic breast cancer was 33.3 percent.
It's amazing how we feel the need to apologize. We want to make others comfortable. Sometimes it just doesn't work.
The DigniCap Cooling System reduces the severity and frequency of hair loss in patients receiving chemotherapy for breast cancer.
Millions of people worldwide hear these words every year.
Cancer hit me with guilt the moment it came into my life. Even now, six years later, it's still part of my cancer experience.
While recent advances in breast cancer therapy have resulted in survival gains, many patients and survivors have an increased risk of cardiovascular adverse events following treatment.
The treatment paradigm for patients with triple-negative breast cancer is set to undergo a dramatic transformation, as standard chemotherapeutic approaches are perfected and novel antibody-drug conjugates are developed.
My mother chose to live by asking for help, and so can I.
Pharmacies hopefully aim to help all their patients feel better, yet a common practice is making some patients feel worse. You can do something about it.
Two-time cancer survivor discusses her fatigue and possible answers for it.
A little insight into what kids see when you don't know they're looking, and how I came in second place to Thomas Edison.
A male breast cancer survivor looks at the science of life and death.
Women who performed 150 minutes of treadmill exercise per week and those who exercised twice that amount showed estrogen-sensitive breast tissue reductions of 8 percent and 12 percent, respectively.
How you make a decision is sometimes as important as the decision you make.
Receiving a cancer diagnosis is a turning point, a moment at which patients need to start determining what seems like the right treatment path and exerting their best efforts to make it happen.
Treatment for breast cancer is progressing ever forward, with new options routinely making their way into the oncologist's toolbox.
Choosing a treatment based on data can be fraught with challenges, but it can make all the difference.
Certain drugs target estrogen receptor-positive or HER2-positive breast cancers. Research is examining whether better drugs or combinations can improve outcomes.
Radiation therapy after surgery can help prevent the local recurrence of breast cancer, and new methods are allowing doctors to tailor the technique to meet the needs of individual patients.
Your loved ones and an army of health care providers can help you win.
It is a woman's choice to advocate for themselves, while assessing the risk for these types of tests that are available.
Amid debate about how much screening should be used to detect breast cancer, women at average risk should know the pros and cons.
Cancer is a terrifying word. Here's how to let the patient know the news is bad.
In terms of both treatment and the emotional perspective of patients, metastatic breast cancer is different from other stages of the disease.
"I think I can, I think I can," says a two-time cancer survivor.